MA45177A - Traitement de la maladie de parkinson - Google Patents
Traitement de la maladie de parkinsonInfo
- Publication number
- MA45177A MA45177A MA045177A MA45177A MA45177A MA 45177 A MA45177 A MA 45177A MA 045177 A MA045177 A MA 045177A MA 45177 A MA45177 A MA 45177A MA 45177 A MA45177 A MA 45177A
- Authority
- MA
- Morocco
- Prior art keywords
- parkinson
- disease
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN201621019087 | 2016-06-02 | ||
| PCT/IN2017/050224 WO2017208267A1 (fr) | 2016-06-02 | 2017-06-02 | Traitement de la maladie de parkinson |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MA45177A true MA45177A (fr) | 2019-04-10 |
| MA45177B1 MA45177B1 (fr) | 2022-08-31 |
Family
ID=83280007
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA45177A MA45177B1 (fr) | 2016-06-02 | 2017-06-02 | Traitement de la maladie de parkinson |
Country Status (1)
| Country | Link |
|---|---|
| MA (1) | MA45177B1 (fr) |
-
2017
- 2017-06-02 MA MA45177A patent/MA45177B1/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MA45177B1 (fr) | 2022-08-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA49402A (fr) | Polynucléotides aadc pour le traitement de la maladie de parkinson | |
| MA45192A (fr) | Traitement d'association | |
| MA45149A (fr) | Méthodes de traitement de la maladie d'alzheimer | |
| MA41115A (fr) | Procédé de traitement de la maladie d'alzheimer | |
| MA52631A (fr) | Compositions et méthodes pour le traitement de la maladie de parkinson | |
| MA53329A (fr) | Méthodes de traitement de l'épilepsie | |
| MA46353A (fr) | Méthodes de traitement de l'infertilité féminine | |
| IL263188B (en) | Treatment for Parkinson's disease | |
| MA43106A (fr) | Traitement de l'oligo-ovulation associée à la stéatose hepatique | |
| DK3548061T3 (da) | Behandling af neurologiske sygdomme | |
| MA47395A (fr) | Méthode pour le traitement d'une maladie neurologique | |
| MA54792A (fr) | Compositions et méthodes pour le traitement de la maladie de parkinson | |
| EP3458045A4 (fr) | Traitement de la maladie de ménière | |
| FR3044227B1 (fr) | Derives aminophosphiniques pour la prevention et le traitement des douleurs oculaires | |
| MA41782A (fr) | Traitement de patients atteints de diabète de type 2 | |
| MA41090A (fr) | Antagoniste de a2a faiblement dosé pour le traitement du tdah et de la maladie de parkinson | |
| MA48625A (fr) | Composés et méthodes de traitement de la douleur viscérale | |
| MA45177A (fr) | Traitement de la maladie de parkinson | |
| FR3031112B1 (fr) | Construction d'adn pour le traitement de pathologies oculaires | |
| MA40065A (fr) | N, n-bis-2-mercaptoéthyle isophtalamide pour le traitement de la maladie de parkinson | |
| MA47595A (fr) | Méthodes de traitement d'affections neurodégénératives | |
| ZA201801945B (en) | Compositions and methods for the treatment of parkinson's disease | |
| KR20180085033A (ko) | 피부 질환 치료용 약학적 제형 및 이의 제조 방법 | |
| FR3052669B1 (fr) | Prothese biologique destinee au traitement des hernies parastomales | |
| FR3016881B1 (fr) | Traitement des degenerescences et des lesions photo-induites de la retine |